Glycomics Market Report: Trends, Forecast and Competitive Analysis
Get it in 2 to 4 weeks by ordering today
The future of the global glycomics market looks promising with opportunities in drug discovery & development and disease diagnostics. The global glycomics market is expected to grow with a CAGR of 13%-15% from 2020 to 2025. The major drivers for this market are increasing research and development activities related to drug discovery, rising investment by governments and organizations for academic research for development of new glycomics and glycobiology tools, and growing proteomics market.
A total of XX figures / charts and XX tables are provided in more than 150 pages report to help in your business decisions. Sample figures with some insights are shown below. To learn the scope, benefits, companies researched, and other details of the global glycomics market report, please download the report brochure.
In this market, drug discovery and development is the largest application of glycomics, whereas academic research and institutes is the largest end user. Growth in various segments of the glycomics market are given below:
The study includes trends and forecast for the global glycomics market by product, application, end user, and region as follows:
By Product [Value ($ Million) shipment analysis for 2014 – 2025]:
EnzymesGlycosidases & NeuramidasesGlycosyltransferases & SialyltransferasesOther EnzymesInstrumentsMass Spectrometry InstrumentsChromatography InstrumentsArraysOther InstrumentsCarbohydratesOligosaccharidesMonosaccharidesOther CarbohydratesReagents & Chemicals
By Application [Value ($ Million) shipment analysis for 2014 – 2025]:
Drug Discovery & DevelopmentDisease DiagnosticsCancer DiagnosticsOther Disease DiagnosticsOther Applications
By End User [Value ($ Million) shipment analysis for 2014 – 2025]:
Academic Research InstitutesPharmaceutical and Biotechnology CompaniesClinical Laboratories
By Region [Value ($ Million) shipment analysis for 2014 – 2025]:
North AmericaUnited StatesCanada MexicoEuropeUnited KingdomSpainGermanyFranceAsia PacificChinaIndiaJapanThe Rest of the WorldBrazil
Some of the glycomics companies profiled in this report include Merck, Agilent Technologies, Thermo Fisher Scientific, New England Biolabs, Shimadzu Corporation, Takara Bio, S-BIO, Waters Corporation, Asparia Glycomics, and Bio-Techne.
Lucintel forecasts that the drug discovery and development will remain the largest segment over the forecast period due to increasing research and development activities related to glycomics and proteomics.
Within this market, academic and research institutes will remain the largest segment over the forecast period due to increasing research and development activities and growing adoption of glycan structure data analysis by research centers.
North America will remain the largest region over the forecast period due to government fundings for research and development activities and presence of advanced healthcare infrastructure in the region.
Features of the Global Glycomics Market
Market Size Estimates: Global glycomics market size estimation in terms of value ($M) shipment.Trend and Forecast Analysis: Market trends (2014-2019) and forecast (2020-2025) by various segments.Segmentation Analysis: Global glycomics market size by various segments, such as product, application, and end user in terms of value.Regional Analysis: Global glycomics market breakdown by the North America, Europe, Asia Pacific, and Rest of the World.Growth Opportunities: Analysis of growth opportunities in different product, application, end user, and region for the global glycomics market.Strategic Analysis: This includes M&A, new product development, and competitive landscape of the global glycomics market.Analysis of competitive intensity of the industry based on Porter’s Five Forces model.
This report answers following key questions
Q.1 What are some of the most promising potential, high-growth opportunities for the global glycomics market by product (enzymes (glycosidases & neuramidases, glycosyltransferases & sialyltransferases, and other enzymes), instruments (mass spectrometry instruments, chromatography instruments, arrays, and other instruments), carbohydrates (oligosaccharides, monosaccharides, and other carbohydrates), and reagents & chemicals), application (drug discovery & development, disease diagnostics (cancer diagnostics and other disease diagnostics), and other applications), end user (academic research institutes, pharmaceutical & biotechnology companies, and clinical laboratories), and region (North America, Europe, Asia Pacific, and Rest of the World)?
Q.2 Which segments will grow at a faster pace and why?
Q.3 Which region will grow at a faster pace and why?
Q.4 What are the key factors affecting market dynamics? What are the drivers and challenges of the global glycomics market?
Q.5 What are the business risks and threats to the global glycomics market?
Q.6 What are emerging trends in this glycomics market and the reasons behind them?
Q.7 What are some changing demands of customers in this glycomics market?
Q.8 What are the new developments in this glycomics market? Which companies are leading these developments?
Q.9 Who are the major players in this glycomics market? What strategic initiatives are being implemented by key players for business growth?
Q.10 What are some of the competitive products and processes in this glycomics market, and how big of a threat do they pose for loss of market share via material or product substitution?
Q.11 What M&A activities did take place in the last five years in the global glycomics market?
Report Scope
Key Features Description
Base Year for Estimation 2019
Trend Period
(Actual Estimates) 2014-2019
Forecast Period 2020-2025
Pages More than 150
Market Representation / Units Revenue in US $ Million
Report Coverage Market Trends & Forecasts, Competitor Analysis, New Product Development, Company Expansion, Merger, Acquisitions & Joint Venture, and Company Profiling
Market Segments Product (Enzymes (Glycosidases & Neuramidases, Glycosyltransferases & Sialyltransferases, and Other Enzymes), Instruments (Mass Spectrometry Instruments, Chromatography Instruments, Arrays, and Other Instruments), Carbohydrates (Oligosaccharides, Monosaccharides, and Other Carbohydrates), and Reagents & Chemicals), Application (Drug Discovery & Development, Disease Diagnostics (Cancer Diagnostics and Other Disease Diagnostics), and Other Applications), and End User (Academic Research Institutes, Pharmaceutical & Biotechnology Companies, and Clinical Laboratories)
Regional Scope North America (USA, Mexico, and Canada), Europe (United Kingdom, Spain, Germany, and France), Asia (China, India, and Japan), and ROW (Brazil)
Customization 10% Customization without Any Additional Cost
The future of the global glycomics market looks promising with opportunities in drug discovery & development and disease diagnostics. The global glycomics market is expected to grow with a CAGR of 13%-15% from 2020 to 2025. The major drivers for this market are increasing research and development activities related to drug discovery, rising investment by governments and organizations for academic research for development of new glycomics and glycobiology tools, and growing proteomics market.
A total of XX figures / charts and XX tables are provided in more than 150 pages report to help in your business decisions. Sample figures with some insights are shown below. To learn the scope, benefits, companies researched, and other details of the global glycomics market report, please download the report brochure.
In this market, drug discovery and development is the largest application of glycomics, whereas academic research and institutes is the largest end user. Growth in various segments of the glycomics market are given below:
The study includes trends and forecast for the global glycomics market by product, application, end user, and region as follows:
By Product [Value ($ Million) shipment analysis for 2014 – 2025]:
EnzymesGlycosidases & NeuramidasesGlycosyltransferases & SialyltransferasesOther EnzymesInstrumentsMass Spectrometry InstrumentsChromatography InstrumentsArraysOther InstrumentsCarbohydratesOligosaccharidesMonosaccharidesOther CarbohydratesReagents & Chemicals
By Application [Value ($ Million) shipment analysis for 2014 – 2025]:
Drug Discovery & DevelopmentDisease DiagnosticsCancer DiagnosticsOther Disease DiagnosticsOther Applications
By End User [Value ($ Million) shipment analysis for 2014 – 2025]:
Academic Research InstitutesPharmaceutical and Biotechnology CompaniesClinical Laboratories
By Region [Value ($ Million) shipment analysis for 2014 – 2025]:
North AmericaUnited StatesCanada MexicoEuropeUnited KingdomSpainGermanyFranceAsia PacificChinaIndiaJapanThe Rest of the WorldBrazil
Some of the glycomics companies profiled in this report include Merck, Agilent Technologies, Thermo Fisher Scientific, New England Biolabs, Shimadzu Corporation, Takara Bio, S-BIO, Waters Corporation, Asparia Glycomics, and Bio-Techne.
Lucintel forecasts that the drug discovery and development will remain the largest segment over the forecast period due to increasing research and development activities related to glycomics and proteomics.
Within this market, academic and research institutes will remain the largest segment over the forecast period due to increasing research and development activities and growing adoption of glycan structure data analysis by research centers.
North America will remain the largest region over the forecast period due to government fundings for research and development activities and presence of advanced healthcare infrastructure in the region.
Features of the Global Glycomics Market
Market Size Estimates: Global glycomics market size estimation in terms of value ($M) shipment.Trend and Forecast Analysis: Market trends (2014-2019) and forecast (2020-2025) by various segments.Segmentation Analysis: Global glycomics market size by various segments, such as product, application, and end user in terms of value.Regional Analysis: Global glycomics market breakdown by the North America, Europe, Asia Pacific, and Rest of the World.Growth Opportunities: Analysis of growth opportunities in different product, application, end user, and region for the global glycomics market.Strategic Analysis: This includes M&A, new product development, and competitive landscape of the global glycomics market.Analysis of competitive intensity of the industry based on Porter’s Five Forces model.
This report answers following key questions
Q.1 What are some of the most promising potential, high-growth opportunities for the global glycomics market by product (enzymes (glycosidases & neuramidases, glycosyltransferases & sialyltransferases, and other enzymes), instruments (mass spectrometry instruments, chromatography instruments, arrays, and other instruments), carbohydrates (oligosaccharides, monosaccharides, and other carbohydrates), and reagents & chemicals), application (drug discovery & development, disease diagnostics (cancer diagnostics and other disease diagnostics), and other applications), end user (academic research institutes, pharmaceutical & biotechnology companies, and clinical laboratories), and region (North America, Europe, Asia Pacific, and Rest of the World)?
Q.2 Which segments will grow at a faster pace and why?
Q.3 Which region will grow at a faster pace and why?
Q.4 What are the key factors affecting market dynamics? What are the drivers and challenges of the global glycomics market?
Q.5 What are the business risks and threats to the global glycomics market?
Q.6 What are emerging trends in this glycomics market and the reasons behind them?
Q.7 What are some changing demands of customers in this glycomics market?
Q.8 What are the new developments in this glycomics market? Which companies are leading these developments?
Q.9 Who are the major players in this glycomics market? What strategic initiatives are being implemented by key players for business growth?
Q.10 What are some of the competitive products and processes in this glycomics market, and how big of a threat do they pose for loss of market share via material or product substitution?
Q.11 What M&A activities did take place in the last five years in the global glycomics market?
Report Scope
Key Features Description
Base Year for Estimation 2019
Trend Period
(Actual Estimates) 2014-2019
Forecast Period 2020-2025
Pages More than 150
Market Representation / Units Revenue in US $ Million
Report Coverage Market Trends & Forecasts, Competitor Analysis, New Product Development, Company Expansion, Merger, Acquisitions & Joint Venture, and Company Profiling
Market Segments Product (Enzymes (Glycosidases & Neuramidases, Glycosyltransferases & Sialyltransferases, and Other Enzymes), Instruments (Mass Spectrometry Instruments, Chromatography Instruments, Arrays, and Other Instruments), Carbohydrates (Oligosaccharides, Monosaccharides, and Other Carbohydrates), and Reagents & Chemicals), Application (Drug Discovery & Development, Disease Diagnostics (Cancer Diagnostics and Other Disease Diagnostics), and Other Applications), and End User (Academic Research Institutes, Pharmaceutical & Biotechnology Companies, and Clinical Laboratories)
Regional Scope North America (USA, Mexico, and Canada), Europe (United Kingdom, Spain, Germany, and France), Asia (China, India, and Japan), and ROW (Brazil)
Customization 10% Customization without Any Additional Cost
1. EXECUTIVE SUMMARY
2. MARKET BACKGROUND AND CLASSIFICATIONS
2.1: Introduction, Background, and Classifications
2.2: Supply Chain
2.3: Industry Drivers and Challenges
3. MARKET TRENDS AND FORECAST ANALYSIS FROM 2014 T 2025
3.1: Macroeconomic Trends and Forecast
3.2: Global Glycomics Market Trends and Forecast
3.3: Global Glycomics Market by Product
3.3.1: Enzymes
3.3.1.1: Glycosidases & Neuramidases
3.3.1.2: Glycosyltransferases & Sialyltransferases
3.3.1.3: Other Enzymes
3.3.2: Instruments
3.3.2.1: Mass Spectrometry Instruments
3.3.2.2: Chromatography Instruments
3.3.2.3: Arrays
3.3.2.4: Other Instruments)
3.3.3: Carbohydrates
3.3.3.1: Oligosaccharides
3.3.3.2: Monosaccharides
3.3.3.3: Other Carbohydrates
3.3.4: Reagents & Chemicals
3.4: Global Glycomics Market by Application
3.4.1: Drug Discovery & Development
3.4.2: Disease Diagnostics
3.4.2.1: Cancer Diagnostics
3.4.2.2: Other Disease Diagnostics
3.4.3: Other Applications
3.5: Global Glycomics Market by End User
3.5.1: Academic Research Institutes
3.5.2: Pharmaceutical & Biotechnology Companies
3.5.3: Clinical Laboratories
4. MARKET TRENDS AND FORECAST ANALYSIS BY REGION
4.1: Global Glycomics Market by Region
4.2: North American Glycomics Market
4.2.1: Market by Product: Enzymes (Glycosidases & Neuramidases, Glycosyltransferases & Sialyltransferases, and Other Enzymes), Instruments (Mass Spectrometry Instruments, Chromatography Instruments, Arrays, and Other Instruments), Carbohydrates (Oligosaccharides, Monosaccharides, and Other Carbohydrates), and Reagents & Chemicals
4.2.2: Market by Application: Drug Discovery & Development, Disease Diagnostics (Cancer Diagnostics and Other Disease Diagnostics), and Other Applications
4.2.3: Market by End User: Academic Research Institutes, Pharmaceutical & Biotechnology Companies, and Clinical Laboratories
4.2.4: The United States Glycomics Market
4.2.5: The Canadian Glycomics Market
4.2.6: The Mexican Glycomics Market
4.3: European Glycomics Market
4.3.1: Market by Product: Enzymes (Glycosidases & Neuramidases, Glycosyltransferases & Sialyltransferases, and Other Enzymes), Instruments (Mass Spectrometry Instruments, Chromatography Instruments, Arrays, and Other Instruments), Carbohydrates (Oligosaccharides, Monosaccharides, and Other Carbohydrates), and Reagents & Chemicals
4.3.2: Market by Application: Drug Discovery & Development, Disease Diagnostics (Cancer Diagnostics and Other Disease Diagnostics), and Other Applications
4.3.3: Market by End User: Academic Research Institutes, Pharmaceutical & Biotechnology Companies, and Clinical Laboratories
4.3.4: The Glycomics Market of United Kingdom
4.3.5: The Spanish Glycomics Market
4.3.6: The German Glycomics Market
4.3.7: The French Glycomics Market
4.4: APAC Glycomics Market
4.4.1: Market by Product: Enzymes (Glycosidases & Neuramidases, Glycosyltransferases & Sialyltransferases, and Other Enzymes), Instruments (Mass Spectrometry Instruments, Chromatography Instruments, Arrays, and Other Instruments), Carbohydrates (Oligosaccharides, Monosaccharides, and Other Carbohydrates), and Reagents & Chemicals
4.4.2: Market by Application: Drug Discovery & Development, Disease Diagnostics (Cancer Diagnostics and Other Disease Diagnostics), and Other Applications
4.4.3: Market by End User: Academic Research Institutes, Pharmaceutical & Biotechnology Companies, and Clinical Laboratories
4.4.4: The Chinese Glycomics Market
4.4.5: The Indian Glycomics Market
4.4.6: The Vietnamese Glycomics Market
4.5: ROW Glycomics Market
4.5.1: Market by Product: Enzymes (Glycosidases & Neuramidases, Glycosyltransferases & Sialyltransferases, and Other Enzymes), Instruments (Mass Spectrometry Instruments, Chromatography Instruments, Arrays, and Other Instruments), Carbohydrates (Oligosaccharides, Monosaccharides, and Other Carbohydrates), and Reagents & Chemicals
4.5.2: Market by Application: Drug Discovery & Development, Disease Diagnostics (Cancer Diagnostics and Other Disease Diagnostics), and Other Applications
4.5.3: Market by End User: Academic Research Institutes, Pharmaceutical & Biotechnology Companies, and Clinical Laboratories
4.5.4: Brazilian Glycomics Market
5. COMPETITOR ANALYSIS
5.1: Market Share Analysis
5.2: Product Portfoli Analysis
5.3: Operational Integration
5.4: Geographical Reach
5.5: Porter’s Five Forces Analysis
6. COST STRUCTURE ANALYSIS
6.1: Cost of Goods Sold
6.2: SG&A
6.3: EBITDA Margin
7. GROWTH OPPORTUNITIES AND STRATEGIC ANALYSIS
7.1: Growth Opportunity Analysis
7.1.1: Growth Opportunities for the Global Glycomics Market by Product
7.1.2: Growth Opportunities for the Global Glycomics Market by Application
7.1.3: Growth Opportunities for the Global Glycomics Market by End User
7.1.4: Growth Opportunities for the Global Glycomics Market by Region
7.2: Emerging Trends in the Global Glycomics Market
7.3: Strategic Analysis
7.3.1: New Product Development
7.3.2: Capacity Expansion of the Global Glycomics Market
7.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Glycomics Market
7.3.4: Certification and Licensing
8. COMPANY PROFILES OF LEADING PLAYERS
8.1: Merck KGaA
8.2: Agilent Technologies, Inc.
8.3: Therm Fisher Scientific, Inc.
8.4: New England Biolabs, Inc.
8.5: Shimadzu Corporation
8.6: Takara Bio, Inc.
8.7: S-BIO
8.8: Waters Corporation
8.9: Asparia Glycomics S.L.
8.10: Bio-Techne Corporation
2. MARKET BACKGROUND AND CLASSIFICATIONS
2.1: Introduction, Background, and Classifications
2.2: Supply Chain
2.3: Industry Drivers and Challenges
3. MARKET TRENDS AND FORECAST ANALYSIS FROM 2014 T 2025
3.1: Macroeconomic Trends and Forecast
3.2: Global Glycomics Market Trends and Forecast
3.3: Global Glycomics Market by Product
3.3.1: Enzymes
3.3.1.1: Glycosidases & Neuramidases
3.3.1.2: Glycosyltransferases & Sialyltransferases
3.3.1.3: Other Enzymes
3.3.2: Instruments
3.3.2.1: Mass Spectrometry Instruments
3.3.2.2: Chromatography Instruments
3.3.2.3: Arrays
3.3.2.4: Other Instruments)
3.3.3: Carbohydrates
3.3.3.1: Oligosaccharides
3.3.3.2: Monosaccharides
3.3.3.3: Other Carbohydrates
3.3.4: Reagents & Chemicals
3.4: Global Glycomics Market by Application
3.4.1: Drug Discovery & Development
3.4.2: Disease Diagnostics
3.4.2.1: Cancer Diagnostics
3.4.2.2: Other Disease Diagnostics
3.4.3: Other Applications
3.5: Global Glycomics Market by End User
3.5.1: Academic Research Institutes
3.5.2: Pharmaceutical & Biotechnology Companies
3.5.3: Clinical Laboratories
4. MARKET TRENDS AND FORECAST ANALYSIS BY REGION
4.1: Global Glycomics Market by Region
4.2: North American Glycomics Market
4.2.1: Market by Product: Enzymes (Glycosidases & Neuramidases, Glycosyltransferases & Sialyltransferases, and Other Enzymes), Instruments (Mass Spectrometry Instruments, Chromatography Instruments, Arrays, and Other Instruments), Carbohydrates (Oligosaccharides, Monosaccharides, and Other Carbohydrates), and Reagents & Chemicals
4.2.2: Market by Application: Drug Discovery & Development, Disease Diagnostics (Cancer Diagnostics and Other Disease Diagnostics), and Other Applications
4.2.3: Market by End User: Academic Research Institutes, Pharmaceutical & Biotechnology Companies, and Clinical Laboratories
4.2.4: The United States Glycomics Market
4.2.5: The Canadian Glycomics Market
4.2.6: The Mexican Glycomics Market
4.3: European Glycomics Market
4.3.1: Market by Product: Enzymes (Glycosidases & Neuramidases, Glycosyltransferases & Sialyltransferases, and Other Enzymes), Instruments (Mass Spectrometry Instruments, Chromatography Instruments, Arrays, and Other Instruments), Carbohydrates (Oligosaccharides, Monosaccharides, and Other Carbohydrates), and Reagents & Chemicals
4.3.2: Market by Application: Drug Discovery & Development, Disease Diagnostics (Cancer Diagnostics and Other Disease Diagnostics), and Other Applications
4.3.3: Market by End User: Academic Research Institutes, Pharmaceutical & Biotechnology Companies, and Clinical Laboratories
4.3.4: The Glycomics Market of United Kingdom
4.3.5: The Spanish Glycomics Market
4.3.6: The German Glycomics Market
4.3.7: The French Glycomics Market
4.4: APAC Glycomics Market
4.4.1: Market by Product: Enzymes (Glycosidases & Neuramidases, Glycosyltransferases & Sialyltransferases, and Other Enzymes), Instruments (Mass Spectrometry Instruments, Chromatography Instruments, Arrays, and Other Instruments), Carbohydrates (Oligosaccharides, Monosaccharides, and Other Carbohydrates), and Reagents & Chemicals
4.4.2: Market by Application: Drug Discovery & Development, Disease Diagnostics (Cancer Diagnostics and Other Disease Diagnostics), and Other Applications
4.4.3: Market by End User: Academic Research Institutes, Pharmaceutical & Biotechnology Companies, and Clinical Laboratories
4.4.4: The Chinese Glycomics Market
4.4.5: The Indian Glycomics Market
4.4.6: The Vietnamese Glycomics Market
4.5: ROW Glycomics Market
4.5.1: Market by Product: Enzymes (Glycosidases & Neuramidases, Glycosyltransferases & Sialyltransferases, and Other Enzymes), Instruments (Mass Spectrometry Instruments, Chromatography Instruments, Arrays, and Other Instruments), Carbohydrates (Oligosaccharides, Monosaccharides, and Other Carbohydrates), and Reagents & Chemicals
4.5.2: Market by Application: Drug Discovery & Development, Disease Diagnostics (Cancer Diagnostics and Other Disease Diagnostics), and Other Applications
4.5.3: Market by End User: Academic Research Institutes, Pharmaceutical & Biotechnology Companies, and Clinical Laboratories
4.5.4: Brazilian Glycomics Market
5. COMPETITOR ANALYSIS
5.1: Market Share Analysis
5.2: Product Portfoli Analysis
5.3: Operational Integration
5.4: Geographical Reach
5.5: Porter’s Five Forces Analysis
6. COST STRUCTURE ANALYSIS
6.1: Cost of Goods Sold
6.2: SG&A
6.3: EBITDA Margin
7. GROWTH OPPORTUNITIES AND STRATEGIC ANALYSIS
7.1: Growth Opportunity Analysis
7.1.1: Growth Opportunities for the Global Glycomics Market by Product
7.1.2: Growth Opportunities for the Global Glycomics Market by Application
7.1.3: Growth Opportunities for the Global Glycomics Market by End User
7.1.4: Growth Opportunities for the Global Glycomics Market by Region
7.2: Emerging Trends in the Global Glycomics Market
7.3: Strategic Analysis
7.3.1: New Product Development
7.3.2: Capacity Expansion of the Global Glycomics Market
7.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Glycomics Market
7.3.4: Certification and Licensing
8. COMPANY PROFILES OF LEADING PLAYERS
8.1: Merck KGaA
8.2: Agilent Technologies, Inc.
8.3: Therm Fisher Scientific, Inc.
8.4: New England Biolabs, Inc.
8.5: Shimadzu Corporation
8.6: Takara Bio, Inc.
8.7: S-BIO
8.8: Waters Corporation
8.9: Asparia Glycomics S.L.
8.10: Bio-Techne Corporation
